Trial Profile
A Phase 1, Single-center, Randomized, Vehicle-controlled, Parallel-cohort Study Of Crisaborole Ointment 2% To Evaluate The Skin Irritation Potential In Adult Japanese Healthy Subjects, And To Evaluate The Safety, Tolerability And Pharmacokinetics In Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Pfizer
- 07 Dec 2017 Status changed from active, no longer recruiting to completed.
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 25 Sep 2017 Status changed from not yet recruiting to recruiting.